Disruption of central nervous system barriers in multiple sclerosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 2, 2011, Pages 252-264

  Alvarez, Jorge Ivan ^a   Cayrol, Romain ^a   Prat, Alexandre ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

Adherens junctions; ALCAM; Astrocyte; Basal lamina; Basement membrane; BBB; BCB; CAMs; Chemokine; Choroid plexus; EAE; ECM; Endothelial cells; Ependyma; ICAM 1; MS; Neuroinflammation; P selectin; Pericyte; Tight junctions; Transmigration; VCAM 1; VLA 4

Indexed keywords

CELL ADHESION MOLECULE; INTEGRIN; NATALIZUMAB; SELECTIN;

ALLERGIC ENCEPHALOMYELITIS; ANTIINFLAMMATORY ACTIVITY; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN DAMAGE; CELL ADHESION; CELL COMPOSITION; CELL CYCLE ARREST; CELL INFILTRATION; CELL MIGRATION; CYTOKINE PRODUCTION; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LEUKOCYTE MIGRATION; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; TIGHT JUNCTION; UPREGULATION;

MURINAE;

EID: 78650173611     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.06.017     Document Type: Review

References (219)

1. Abbott N.J. Astrocyte-endothelial interactions and blood-brain barrier permeability. J. Anat. 2002, 200:629.
2. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41.
3. Adamson P., Etienne S., Couraud P.O., Calder V., Greenwood J. Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J. Immunol. 1999, 162:2964.
4. Agrawal S., Anderson P., Durbeej M., van Rooijen N., Ivars F., Opdenakker G., Sorokin L.M. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 2006, 203:1007.
5. Agrawal S.M., Yong V.W. Immunopathogenesis of multiple sclerosis. Int. Rev. Neurobiol. 2007, 79:99.
6. Airas L., Mikkola J., Vainio J.M., Elovaara I., Smith D.J. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. J. Neuroimmunol. 2006, 177:132.
7. Alvarez J.I., Dodelet-Devillers A., Ifergan I., Bernard M., van Horssen J., Charron F., Prat A. Astrocyte-secreted sonic hedgehog supports CNS anti-inflammatory activity and promotes optimal human blood brain barrier functioning. Clin. Immunol. 2009, 131:S34.
8. Alvarez J.I., Teale J.M. Differential changes in junctional complex proteins suggest the ependymal lining as the main source of leukocyte infiltration into ventricles in murine neurocysticercosis. J. Neuroimmunol. 2007, 187:102.
9. Alvarez J.I., Teale J.M. Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res. 2007, 1169:98.
10. Andreeva A.V., Han J., Kutuzov M.A., Profirovic J., Tkachuk V.A., Voyno-Yasenetskaya T.A. T-cadherin modulates endothelial barrier function. J. Cell. Physiol. 2010, 223:94.
11. Antonetti D.A., Barber A.J., Hollinger L.A., Wolpert E.B., Gardner T.W. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J. Biol. Chem. 1999, 274:23463.
12. Antonetti D.A., Wolpert E.B., DeMaio L., Harhaj N.S., Scaduto R.C. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J. Neurochem. 2002, 80:667.
13. Armulik A., Abramsson A., Betsholtz C. Endothelial/pericyte interactions. Circ. Res. 2005, 97:512.
14. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001, 21:7724.
15. Aurrand-Lions M., Johnson-Leger C., Wong C., Du P.L., Imhof B.A. Heterogeneity of endothelial junctions is reflected by differential expression and specific subcellular localization of the three JAM family members. Blood 2001, 98:3699.
16. Badovinac V., Mostarica-Stojkovic M., Dinarello C.A., Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J. Neuroimmunol. 1998, 85:87.
17. Balabanov R., Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J. Neurosci. Res. 1998, 53:637.
18. Balabanov R., Washington R., Wagnerova J., Dore-Duffy P. CNS microvascular pericytes express macrophage-like function, cell surface integrin alpha M, and macrophage marker ED-2. Microvasc. Res. 1996, 52:127.
19. Ballabh P., Braun A., Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16:1.
20. Bar-Or A., Nuttall R.K., Duddy M., Alter A., Kim H.J., Ifergan I., Pennington C.J., Bourgoin P., Edwards D.R., Yong V.W. Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis. Brain 2003, 126:2738.
21. Bartholomaus I., Kawakami N., Odoardi F., Schlager C., Miljkovic D., Ellwart J.W., Klinkert W.E., Flugel-Koch C., Issekutz T.B., Wekerle H., Flugel A. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462:94.
22. Barton E.S., Forrest J.C., Connolly J.L., Chappell J.D., Liu Y., Schnell F.J., Nusrat A., Parkos C.A., Dermody T.S. Junction adhesion molecule is a receptor for reovirus. Cell 2001, 104:441.
23. Battistini L., Piccio L., Rossi B., Bach S., Galgani S., Gasperini C., Ottoboni L., Ciabini D., Caramia M.D., Bernardi G., Laudanna C., Scarpini E., McEver R.P., Butcher E.C., Borsellino G., Constantin G. CD8+ T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1. Blood 2003, 101:4775.
24. Bauer A.T., Burgers H.F., Rabie T., Marti H.H. Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J. Cereb. Blood Flow Metab. 2009.
25. Bazzoni G., Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol. Rev. 2004, 84:869.
26. Bjartmar C., Trapp B.D. Axonal degeneration and progressive neurologic disability in multiple sclerosis. Neurotox. Res. 2003, 5:157.
27. Blum M.S., Toninelli E., Anderson J.M., Balda M.S., Zhou J., O'Donnell L., Pardi R., Bender J.R. Cytoskeletal rearrangement mediates human microvascular endothelial tight junction modulation by cytokines. Am. J. Physiol. 1997, 273:H286-H294.
28. Bolton S.J., Anthony D.C., Perry V.H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil-induced blood-brain barrier breakdown in vivo. Neuroscience 1998, 86:1245.
29. Brennan F.R., O'Neill J.K., Allen S.J., Butter C., Nuki G., Baker D. CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology 1999, 98:427.
30. Brown P.D., Davies S.L., Speake T., Millar I.D. Molecular mechanisms of cerebrospinal fluid production. Neuroscience 2004, 129:957.
31. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 2003, 171:6164.
32. Bruewer M., Utech M., Ivanov A.I., Hopkins A.M., Parkos C.A., Nusrat A. Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J. 2005, 19:923.
33. Bundgaard M., Abbott N.J. All vertebrates started out with a glial blood-brain barrier 4-500 million years ago. Glia 2008, 56:699.
34. Calabresi P.A., Prat A., Biernacki K., Rollins J., Antel J.P. T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells. J. Neuroimmunol. 2001, 115:161.
35. Calabria A.R., Shusta E.V. A genomic comparison of in vivo and in vitro brain microvascular endothelial cells. J. Cereb. Blood Flow Metab. 2008, 28:135.
36. Cannella B., Cross A.H., Raine C.S. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J. Exp. Med. 1990, 172:1521.
37. Cannella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 1995, 37:424.
38. Cardona A.E., Li M., Liu L., Savarin C., Ransohoff R.M. Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J. Leukoc. Biol. 2008.
39. Carman C.V., Springer T.A. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 2004, 167:377.
40. Carrithers M.D., Visintin I., Viret C., Janeway C.S. Role of genetic background in P selectin-dependent immune surveillance of the central nervous system. J. Neuroimmunol. 2002, 129:51.
41. Cayrol R., Wosik K., Berard J.L., Dodelet-Devillers A., Ifergan I., Kebir H., Haqqani A.S., Kreymborg K., Krug S., Moumdjian R., Bouthillier A., Becher B., Arbour N., David S., Stanimirovic D., Prat A. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 2008, 9:137.
42. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J. Med. 2006, 354:610.
43. Chigaev A., Zwartz G., Graves S.W., Dwyer D.C., Tsuji H., Foutz T.D., Edwards B.S., Prossnitz E.R., Larson R.S., Sklar L.A. Alpha4beta1 integrin affinity changes govern cell adhesion. J. Biol. Chem. 2003, 278:38174.
44. de Vries H.E., Hendriks J.J., Honing H., De Lavalette C.R., van der Pol S.M., Hooijberg E., Dijkstra C.D., Van Den Berg T.K. Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium. J. Immunol. 2002, 168:5832.
45. Dejana E., Lampugnani M.G., Martinez-Estrada O., Bazzoni G. The molecular organization of endothelial junctions and their functional role in vascular morphogenesis and permeability. Int. J. Dev. Biol. 2000, 44:743.
46. Dejana E., Orsenigo F., Lampugnani M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 2008, 121:2115.
47. del Zoppo G.J., Milner R., Mabuchi T., Hung S., Wang X., Koziol J.A. Vascular matrix adhesion and the blood-brain barrier. Biochem. Soc. Trans. 2006, 34:1261.
48. Demeure C.E., Tanaka H., Mateo V., Rubio M., Delespesse G., Sarfati M. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 2000, 164:2193.
49. Dodelet-Devillers A., Cayrol R., van Horssen J., Haqqani A.S., de Vries H.E., Engelhardt B., Greenwood J., Prat A. Functions of lipid raft membrane microdomains at the blood-brain barrier. J. Mol. Med. 2009, 87:765.
50. Dohgu S., Takata F., Yamauchi A., Nakagawa S., Egawa T., Naito M., Tsuruo T., Sawada Y., Niwa M., Kataoka Y. Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production. Brain Res. 2005, 1038:208.
51. Dore-Duffy P., Newman W., Balabanov R., Lisak R.P., Mainolfi E., Rothlein R., Peterson M. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann. Neurol. 1995, 37:55.
52. Dore-Duffy P., Washington R., Dragovic L. Expression of endothelial cell activation antigens in microvessels from patients with multiple sclerosis. Adv. Exp. Med. Biol. 1993, 331:243.
53. Doring A., Wild M., Vestweber D., Deutsch U., Engelhardt B. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J. Immunol. 2007, 179:8470.
54. Droogan A.G., McMillan S.A., Douglas J.P., Hawkins S.A. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1. J. Neuroimmunol. 1996, 64:185.
55. Dutta R., Trapp B.D. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007, 68:S22-S31.
56. Engelhardt B. Regulation of immune cell entry into the central nervous system. Results Probl. Cell Differ. 2006, 43:259.
57. Engelhardt B. PSGL-1-the hidden player in T cell trafficking into the brain in multiple sclerosis?. J. Leukoc. Biol. 2009, 86:1023.
58. Engelhardt B., Kappos L. Natalizumab: targeting alpha4-integrins in multiple sclerosis. Neurodegener. Dis. 2008, 5:16.
59. Engelhardt B., Kempe B., Merfeld-Clauss S., Laschinger M., Furie B., Wild M.K., Vestweber D. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice. J. Immunol. 2005, 175:1267.
60. Engelhardt B., Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005, 26:485.
61. Engelhardt B., Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin. Immunopathol. 2009, 31:497.
62. Engelhardt B., Wolburg-Buchholz K., Wolburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc. Res. Tech. 2001, 52:112.
63. Fischer S., Wiesnet M., Renz D., Schaper W. H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur. J. Cell Biol. 2005, 84:687.
64. Friese M.A., Fugger L. Pathogenic CD8(+) T cells in multiple sclerosis. Ann. Neurol. 2009, 66:132.
65. Frohman E.M., Filippi M., Stuve O., Waxman S.G., Corboy J., Phillips J.T., Lucchinetti C., Wilken J., Karandikar N., Hemmer B., Monson N., De Keyser J., Hartung H., Steinman L., Oksenberg J.R., Cree B.A., Hauser S., Racke M.K. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions. Arch. Neurol. 2005, 62:1345.
66. Frohman E.M., Racke M.K., Raine C.S. Multiple sclerosis-the plaque and its pathogenesis. N Engl J. Med. 2006, 354:942.
67. Frohman E.M., Stuve O., Havrdova E., Corboy J., Achiron A., Zivadinov R., Sorensen P.S., Phillips J.T., Weinshenker B., Hawker K., Hartung H.P., Steinman L., Zamvil S., Cree B.A., Hauser S., Weiner H., Racke M.K., Filippi M. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch. Neurol. 2005, 62:1519.
68. Gavard J., Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 2006, 8:1223.
69. Gerhardt H., Wolburg H., Redies C. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev. Dyn. 2000, 218:472.
70. Gijbels K., Van Damme J., Proost P., Put W., Carton H., Billiau A. Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 1990, 20:233.
71. Gloor S.M., Wachtel M., Bolliger M.F., Ishihara H., Landmann R., Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Brain Res. Rev. 2001, 36:258.
72. Gotsch U., Jager U., Dominis M., Vestweber D. Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes. Commun. 1994, 2:7.
73. Graber J., Zhan M., Ford D., Kursch F., Francis G., Bever C., Panitch H., Calabresi P.A., Dhib-Jalbut S. Interferon-beta-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis. J. Neuroimmunol. 2005, 161:169.
74. Graesser D., Mahooti S., Madri J.A. Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2000, 109:121.
75. Greenwood J., Etienne-Manneville S., Adamson P., Couraud P.O. Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier. Vascul. Pharmacol 2002, 38:315.
76. Greenwood J., Wang Y., Calder V.L. Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. off. Immunology 1995, 86:408.
77. Guillemot L., Citi S. Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA. Mol. Biol. Cell 2006, 17:3569.
78. Guillemot L., Paschoud S., Pulimeno P., Foglia A., Citi S. The cytoplasmic plaque of tight junctions: a scaffolding and signalling center. Biochim. Biophys. Acta 2008, 1778:601.
79. Harhaj N.S., Antonetti D.A. Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol. 2004, 36:1206.
80. Harris J.O., Frank J.A., Patronas N., McFarlin D.E., McFarland H.F. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann. Neurol. 1991, 29:548.
81. Hartmann C., Zozulya A., Wegener J., Galla H.J. The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. Exp. Cell Res. 2007, 313:1318.
82. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173.
83. Hayashi K., Nakao S., Nakaoke R., Nakagawa S., Kitagawa N., Niwa M. Effects of hypoxia on endothelial/pericytic co-culture model of the blood-brain barrier. Regul. Pept. 2004, 123:77.
84. Hellstrom M., Gerhardt H., Kalen M., Li X., Eriksson U., Wolburg H., Betsholtz C. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 2001, 153:543.
85. Henderson A.P., Barnett M.H., Parratt J.D., Prineas J.W. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann. Neurol. 2009, 66:739.
86. Hohlfeld R., Wekerle H. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc. Natl Acad. Sci. USA 2004, 101(Suppl 2):14599.
87. Hori S., Ohtsuki S., Hosoya K., Nakashima E., Terasaki T. A pericyte-derived angiopoietin-1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie-2 activation in vitro. J. Neurochem. 2004, 89:503.
88. Huppert J., Closhen D., Croxford A., White R., Kulig P., Pietrowski E., Bechmann I., Becher B., Luhmann H.J., Waisman A., Kuhlmann C.R. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. FASEB J. 2009.
89. Ifergan I., Kebir H., Bernard M., Wosik K., Dodelet-Devillers A., Cayrol R., Arbour N., Prat A. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 2008, 131:785.
90. Ifergan I., Wosik K., Cayrol R., Kebir H., Auger C., Bernard M., Bouthillier A., Moumdjian R., Duquette P., Prat A. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ann. Neurol. 2006, 60:45.
91. Igarashi Y., Utsumi H., Chiba H., Yamada-Sasamori Y., Tobioka H., Kamimura Y., Furuuchi K., Kokai Y., Nakagawa T., Mori M., Sawada N. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem. Biophys. Res. Commun. 1999, 261:108.
92. Ivanov D., Philippova M., Antropova J., Gubaeva F., Iljinskaya O., Tararak E., Bochkov V., Erne P., Resink T., Tkachuk V. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem. Cell Biol. 2001, 115:231.
93. Jaakkola K., Nikula T., Holopainen R., Vahasilta T., Matikainen M.T., Laukkanen M.L., Huupponen R., Halkola L., Nieminen L., Hiltunen J., Parviainen S., Clark M.R., Knuuti J., Savunen T., Kaapa P., Voipio-Pulkki L.M., Jalkanen S. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am. J. Pathol. 2000, 157:463.
94. Jalkanen S., Karikoski M., Mercier N., Koskinen K., Henttinen T., Elima K., Salmivirta K., Salmi M. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 2007, 110:1864.
95. Jalkanen S., Salmi M. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler. Thromb. Vasc. Biol. 2008, 28:18.
96. Jucker M., Tian M., Ingram D.K. Laminins in the adult and aged brain. Mol. Chem. Neuropathol. 1996, 28:209.
97. Kebir H., Ifergan I., Alvarez J.I., Bernard M., Poirier J., Arbour N., Duquette P., Prat A. Preferential recruitment of interferon-gamma-expressing T H 17 cells in multiple sclerosis. Ann. Neurol. 2009, 66:390.
98. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173.
99. Kerfoot S.M., Kubes P. Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J. Immunol. 2002, 169:1000.
100. Kerfoot S.M., Norman M.U., Lapointe B.M., Bonder C.S., Zbytnuik L., Kubes P. Reevaluation of P-selectin and alpha 4 integrin as targets for the treatment of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 176:6225.
101. Kirk J., Plumb J., Mirakhur M., McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201:319.
102. Kivisakk P., Liu Z., Trebst C., Tucky B., Wu L., Stine J., Mack M., Rudick R.A., Campbell J.J., Ransohoff R.M. Flow cytometric analysis of chemokine receptor expression on cerebrospinal fluid leukocytes. Methods 2003, 29:319.
103. Kivisakk P., Mahad D.J., Callahan M.K., Trebst C., Tucky B., Wei T., Wu L., Baekkevold E.S., Lassmann H., Staugaitis S.M., Campbell J.J., Ransohoff R.M. Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A 2003, 100:8389.
104. Kniesel U., Wolburg H. Tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 2000, 20:57.
105. Koning N., Bo L., Hoek R.M., Huitinga I. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann. Neurol. 2007, 62:504.
106. Kraus J., Ling A.K., Hamm S., Voigt K., Oschmann P., Engelhardt B. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann. Neurol. 2004, 56:192.
107. Kraus J., Voigt K., Schuller A.M., Scholz M., Kim K.S., Schilling M., Schabitz W.R., Oschmann P., Engelhardt B. Interferon-beta stabilizes barrier characteristics of the blood-brain barrier in four different species in vitro. Mult. Scler. 2008, 14:843.
108. Krueger M., Bechmann I. CNS pericytes: concepts, misconceptions, and a way out. Glia 2010, 58:1.
109. Lai C.H., Kuo K.H., Leo J.M. Critical role of actin in modulating BBB permeability. Brain Res. Brain Res. Rev. 2005, 50:7.
110. Lalor P.F., Sun P.J., Weston C.J., Martin-Santos A., Wakelam M.J., Adams D.H. Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion. Hepatology 2007, 45:465.
111. Lampugnani M.G., Dejana E. The control of endothelial cell functions by adherens junctions. Novartis Found. Symp. 2007, 283:4.
112. Lassmann H. Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol. 2005, 15:217.
113. Lassmann H., Bruck W., Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol. Med. 2001, 7:115.
114. Lee G., Babakhanian K., Ramaswamy M., Prat A., Wosik K., Bendayan R. Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems. Pharm. Res. 2007, 24:1262.
115. Lee H.S., Namkoong K., Kim D.H., Kim K.J., Cheong Y.H., Kim S.S., Lee W.B., Kim K.Y. Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cells. Microvasc. Res. 2004, 68:231.
116. Lee S.W., Kim W.J., Choi Y.K., Song H.S., Son M.J., Gelman I.H., Kim Y.J., Kim K.W. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 2003, 9:900.
117. Leech S., Kirk J., Plumb J., McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol. Appl. Neurobiol. 2007, 33:86.
118. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678.
119. Lindahl P., Johansson B.R., Leveen P., Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997, 277:242.
120. Lippoldt A., Liebner S., Andbjer B., Kalbacher H., Wolburg H., Haller H., Fuxe K. Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. NeuroReport 2000, 11:1427.
121. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 2005, 6:1182.
122. Mahad D.J., Lawry J., Howell S.J., Woodroofe M.N. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse. Mult. Scler. 2003, 9:189.
123. Man S., Ubogu E.E., Ransohoff R.M. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol. 2007, 17:243.
124. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppacciaro A., Ruco L., Villa A., Simmons D., Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 1998, 142:117.
125. Martinez-Estrada O.M., Villa A., Breviario F., Orsenigo F., Dejana E., Bazzoni G. Association of junctional adhesion molecule with calcium/calmodulin-dependent serine protein kinase (CASK/LIN-2) in human epithelial caco-2 cells. J. Biol. Chem. 2001, 276:9291.
126. Matsuda M., Tsukada N., Koh C.S., Iwahashi T., Shimada K., Yanagisawa N. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in the spinal cord of rats during acute experimental allergic encephalomyelitis. Autoimmunity 1994, 19:15.
127. Matter K., Balda M.S. Holey barrier: claudins and the regulation of brain endothelial permeability. J. Cell Biol. 2003, 161:459.
128. McDonnell G.V., McMillan S.A., Douglas J.P., Droogan A.G., Hawkins S.A. Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease. J. Neurol. 1999, 246:87.
129. McDonnell G.V., McMillan S.A., Douglas J.P., Droogan A.G., Hawkins S.A. Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis. J. Neuroimmunol. 1998, 85:186.
130. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913.
131. McMahon E.J., Bailey S.L., Miller S.D. CNS dendritic cells: critical participants in CNS inflammation?. Neurochem. Int. 2006, 49:195.
132. McQuaid S., Cunnea P., McMahon J., FitzGerald U. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. Biochem. Soc. Trans. 2009, 37:329.
133. Mills J.H., Thompson L.F., Mueller C., Waickman A.T., Jalkanen S., Niemela J., Airas L., Bynoe M.S. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 2008, 105:9325.
134. Nagasawa K., Chiba H., Fujita H., Kojima T., Saito T., Endo T., Sawada N. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J. Cell. Physiol. 2006, 208:123.
135. Naik M.U., Mousa S.A., Parkos C.A., Naik U.P. Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood 2003, 102:2108.
136. Nakagawa S., Deli M.A., Nakao S., Honda M., Hayashi K., Nakaoke R., Kataoka Y., Niwa M. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell. Mol. Neurobiol. 2007, 27:687.
137. Nelson W.J. Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem. Soc. Trans. 2008, 36:149.
138. Neuhaus J., Risau W., Wolburg H. Induction of blood-brain barrier characteristics in bovine brain endothelial cells by rat astroglial cells in transfilter coculture. Ann. NY Acad. Sci. 1991, 633:578.
139. Niemela J., Ifergan I., Yegutkin G.G., Jalkanen S., Prat A., Airas L. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur. J. Immunol. 2008, 38:2718.
140. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 2003, 161:653.
141. Nottebaum A.F., Cagna G., Winderlich M., Gamp A.C., Linnepe R., Polaschegg C., Filippova K., Lyck R., Engelhardt B., Kamenyeva O., Bixel M.G., Butz S., Vestweber D. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J. Exp. Med. 2008, 205:2929.
142. Nourshargh S., Krombach F., Dejana E. The role of JAM-A and PECAM-1 in modulating leukocyte infiltration in inflamed and ischemic tissues. J. Leukoc. Biol. 2006, 80:714.
143. Nusrat A., Turner J.R., Madara J.L. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279:G851-G857.
144. O'Rourke A.M., Wang E.Y., Salter-Cid L., Huang L., Miller A., Podar E., Gao H.F., Jones D.S., Linnik M.D. Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis. J. Neural Transm. 2007, 114:845.
145. Oldenborg P.A., Zheleznyak A., Fang Y.F., Lagenaur C.F., Gresham H.D., Lindberg F.P. Role of CD47 as a marker of self on red blood cells. Science 2000, 288:2051.
146. Ozaki H., Ishii K., Horiuchi H., Arai H., Kawamoto T., Okawa K., Iwamatsu A., Kita T. Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J. Immunol. 1999, 163:553.
147. Padden M., Leech S., Craig B., Kirk J., Brankin B., McQuaid S. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology. Acta Neuropathol. 2007, 113:177.
148. Paik J.H., Skoura A., Chae S.S., Cowan A.E., Han D.K., Proia R.L., Hla T. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev. 2004, 18:2392.
149. Paris L., Tonutti L., Vannini C., Bazzoni G. Structural organization of the tight junctions. Biochim. Biophys. Acta 2008, 1778:646.
150. Park J.A., Lee H.S., Ko K.J., Park S.Y., Kim J.H., Choe G., Kweon H.S., Song H.S., Ahn J.C., Yu Y.S., Kim K.W. Meteorin regulates angiogenesis at the gliovascular interface. Glia 2008, 56:247.
151. Persidsky Y., Ramirez S.H., Haorah J., Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 2006, 1:223.
152. Phelps C.H. The development of glio-vascular relationships in the rat spinal cord. An electron microscopic study. Z. Zellforsch. Mikrosk. Anat. 1972, 128:555.
153. Piccio L., Rossi B., Scarpini E., Laudanna C., Giagulli C., Issekutz A.C., Vestweber D., Butcher E.C., Constantin G. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J. Immunol. 2002, 168:1940.
154. Plumb J., McQuaid S., Mirakhur M., Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002, 12:154.
155. Pokutta S., Drees F., Yamada S., Nelson W.J., Weis W.I. Biochemical and structural analysis of alpha-catenin in cell-cell contacts. Biochem. Soc. Trans. 2008, 36:141.
156. Prat A., Antel J. Pathogenesis of multiple sclerosis. Curr. Opin. Neurol. 2005, 18:225.
157. Prat A., Biernacki K., Becher B., Antel J.P. B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines. J. Neuropathol. Exp. Neurol. 2000, 59:129.
158. Prat A., Biernacki K., Wosik K., Antel J.P. Glial cell influence on the human blood-brain barrier. Glia 2001, 36:145.
159. Rajasekaran A.K., Hojo M., Huima T., Rodriguez-Boulan E. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J. Cell Biol. 1996, 132:451.
160. Ransohoff R.M. The chemokine system in neuroinflammation: an update. J. Infect. Dis. 2002, 186(Suppl 2):S152-S156.
161. Ransohoff R.M. "Thinking without thinking" about natalizumab and PML. J. Neurol. Sci. 2007, 259:50.
162. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569.
163. Rebenko-Moll N.M., Liu L., Cardona A., Ransohoff R.M. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006, 18:683.
164. Reboldi A., Coisne C., Baumjohann D., Benvenuto F., Bottinelli D., Lira S., Uccelli A., Lanzavecchia A., Engelhardt B., Sallusto F. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009, 10:514.
165. Reuss B., Dono R., Unsicker K. Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants. J. Neurosci. 2003, 23:6404.
166. Rubina K., Kalinina N., Potekhina A., Efimenko A., Semina E., Poliakov A., Wilkinson D.G., Parfyonova Y., Tkachuk V. T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells. Angiogenesis 2007, 10:183.
167. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell 2000, 11:4131.
168. Salmi M., Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992, 257:1407.
169. Schreibelt G., Kooij G., Reijerkerk A., van D.R., Gringhuis S.I., van der P.S., Weksler B.B., Romero I.A., Couraud P.O., Piontek J., Blasig I.E., Dijkstra C.D., Ronken E., de Vries H.E. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 2007, 21:3666.
170. Schreibelt G., Musters R.J., Reijerkerk A., de Groot L.R., van der Pol S.M., Hendrikx E.M., Dopp E.D., Dijkstra C.D., Drukarch B., de Vries H.E. Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J. Immunol. 2006, 177:2630.
171. Schreibelt G., van Horssen J., van Rossum S., Dijkstra C.D., Drukarch B., de Vries H.E. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 2007, 56:322.
172. Schreibelt G., van H.J., Haseloff R.F., Reijerkerk A., van der Pol S.M., Nieuwenhuizen O., Krause E., Blasig I.E., Dijkstra C.D., Ronken E., de Vries H.E. Protective effects of peroxiredoxin-1 at the injured blood-brain barrier. Free Radic. Biol. Med. 2008, 45:256.
173. Schulz M., Engelhardt B. The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal. Fluid Res 2005, 2:8.
174. Schulze C., Firth J.A. Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. J. Cell Sci. 1993, 104(Pt 3):773.
175. Segal M.B. Extracellular and cerebrospinal fluids. J. Inherit. Metab. Dis. 1993, 16:617.
176. Shamri R., Grabovsky V., Gauguet J.M., Feigelson S., Manevich E., Kolanus W., Robinson M.K., Staunton D.E., von Andrian U.H., Alon R. Lymphocyte arrest requires instantaneous induction of an extended LFA-1 conformation mediated by endothelium-bound chemokines. Nat. Immunol. 2005, 6:497.
177. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J. Neuroimmunol. 1993, 43:15.
178. Shaw C.E., Dunbar P.R., Macaulay H.A., Neale T.J. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission. J. Neurol. 1995, 242:53.
179. Shin T., Kojima T., Tanuma N., Ishihara Y., Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1995, 56:171.
180. Sixt M., Engelhardt B., Pausch F., Hallmann R., Wendler O., Sorokin L.M. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J. Cell Biol. 2001, 153:933.
181. Sobel R.A., Mitchell M.E., Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 1990, 136:1309.
182. Soilu-Hanninen M., Laaksonen M., Hanninen A. Hyaluronate receptor (CD44) and integrin alpha4 (CD49d) are up-regulated on T cells during MS relapses. J. Neuroimmunol. 2005, 166:189.
183. Sonobe Y., Takeuchi H., Kataoka K., Li H., Jin S., Mimuro M., Hashizume Y., Sano Y., Kanda T., Mizuno T., Suzumura A. Interleukin-25 expressed by brain capillary endothelial cells maintains blood-brain barrier function in a protein kinase Cepsilon-dependent manner. J. Biol. Chem. 2009, 284:31834.
184. Sozen T., Tsuchiyama R., Hasegawa Y., Suzuki H., Jadhav V., Nishizawa S., Zhang J.H. Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice. Stroke 2009, 40:2519.
185. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., Andjelkovic A.V. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir. Suppl. 2006, 96:444.
186. Stamatovic S.M., Keep R.F., Wang M.M., Jankovic I., Andjelkovic A.V. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J. Biol. Chem. 2009, 284:19053.
187. Stamatovic S.M., Shakui P., Keep R.F., Moore B.B., Kunkel S.L., van Rooijen N., Andjelkovic A.V. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 2005, 25:593.
188. Stefanidakis M., Newton G., Lee W.Y., Parkos C.A., Luscinskas F.W. Endothelial CD47 interaction with SIRPgamma is required for human T-cell transendothelial migration under shear flow conditions in vitro. Blood 2008, 112:1280.
189. Steffen B.J., Breier G., Butcher E.C., Schulz M., Engelhardt B. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am. J. Pathol. 1996, 148:1819.
190. Steinman L. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab. Nat. Rev. Drug Discov. 2005, 4:510.
191. Tao-Cheng J.H., Brightman M.W. Development of membrane interactions between brain endothelial cells and astrocytes in vitro. Int. J. Dev. Neurosci. 1988, 6:25.
192. Trapp B.D., Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247.
193. Vajkoczy P., Laschinger M., Engelhardt B. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 2001, 108:557.
194. van Horssen J., Bo L., Dijkstra C.D., de Vries H.E. Extensive extracellular matrix depositions in active multiple sclerosis lesions. Neurobiol. Dis. 2006, 24:484.
195. van Horssen J., Dijkstra C.D., de Vries H.E. The extracellular matrix in multiple sclerosis pathology. J. Neurochem. 2007, 103:1293.
196. Van Itallie C.M., Anderson J.M. The role of claudins in determining paracellular charge selectivity. Proc. Am. Thorac. Soc. 2004, 1:38.
197. van der Valk, Amor S. Preactive lesions in multiple sclerosis. Curr. Opin. Neurol. 2009, 22:207.
198. Verbeek M.M., Westphal J.R., Ruiter D.J., de Waal R.M. T lymphocyte adhesion to human brain pericytes is mediated via very late antigen-4/vascular cell adhesion molecule-1 interactions. J. Immunol. 1995, 154:5876.
199. Vercellino M., Votta B., Condello C., Piacentino C., Romagnolo A., Merola A., Capello E., Mancardi G.L., Mutani R., Giordana M.T., Cavalla P. Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J. Neuroimmunol. 2008, 199:133.
200. Vorbrodt A.W., Dobrogowska D.H. Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res. Brain Res. Rev. 2003, 42:221.
201. Wachtel M., Frei K., Ehler E., Fontana A., Winterhalter K., Gloor S.M. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J. Cell Sci. 1999, 112(Pt 23):4347.
202. Washington R., Burton J., Todd R.F., Newman W., Dragovic L., Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann. Neurol. 1994, 35:89.
203. Waubant E. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis. Markers 2006, 22:235.
204. Weis W.I., Nelson W.J. Re-solving the cadherin-catenin-actin conundrum. J. Biol. Chem. 2006, 281:35593.
205. Wojciak-Stothard B., Entwistle A., Garg R., Ridley A.J. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J. Cell. Physiol. 1998, 176:150.
206. Wojciak-Stothard B., Potempa S., Eichholtz T., Ridley A.J. Rho and Rac but not Cdc42 regulate endothelial cell permeability. J. Cell Sci. 2001, 114:1343.
207. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 2002, 38:323.
208. Wolburg H., Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol. 2010, 119:75.
209. Wong D., Dorovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 1992, 39:11.
210. Wong D., Prameya R., Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 1999, 58:138.
211. Wong R.K., Baldwin A.L., Heimark R.L. Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules. Am. J. Physiol. 1999, 276:H736-H748.
212. Wosik K., Cayrol R., Dodelet-Devillers A., Berthelet F., Bernard M., Moumdjian R., Bouthillier A., Reudelhuber T.L., Prat A. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. J. Neurosci. 2007, 27:9032.
213. Wu C., Ivars F., Anderson P., Hallmann R., Vestweber D., Nilsson P., Robenek H., Tryggvason K., Song J., Korpos E., Loser K., Beissert S., Georges-Labouesse E., Sorokin L.M. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 2009, 15:519.
214. Yamao T., Noguchi T., Takeuchi O., Nishiyama U., Morita H., Hagiwara T., Akahori H., Kato T., Inagaki K., Okazawa H., Hayashi Y., Matozaki T., Takeda K., Akira S., Kasuga M. Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1. J. Biol. Chem. 2002, 277:39833.
215. Yang Y., Estrada E.Y., Thompson J.F., Liu W., Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 2007, 27:697.
216. Yong V.W., Chabot S., Stuve O., Williams G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 1998, 51:682.
217. Youakim A., Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 1999, 276:G1279-G1288.
218. Zhadanov A.B., Provance D.W., Speer C.A., Coffin J.D., Goss D., Blixt J.A., Reichert C.M., Mercer J.A. Absence of the tight junctional protein AF-6 disrupts epithelial cell-cell junctions and cell polarity during mouse development. Curr. Biol. 1999, 9:880.
219. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178.